Skip to content
ppharmaranks
Menu

Best treatments for urinary retention

4 products may treat urinary retention, spanning FDA drug classes such as alpha-adrenergic blocker, cholinesterase inhibitor. The current highest-rated option is cardura. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 4 drugs we list for urinary retention, 3 are available as lower-cost generics, spanning classes such as alpha-adrenergic blocker, cholinesterase inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for urinary retention — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Top-rated picks for urinary retention: 1. Cardura · 2. Neostigmine Methylsulfate · 3. Cardura XL

Top-rated treatments for urinary retention, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$3View →
270/100View →
368/100$3View →
464/100$3View →

Full ranking · 4 treatments

Frequently asked

What treats urinary retention?
Our catalog lists 4 products that may treat urinary retention, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is cardura.
What is the best-rated treatment for urinary retention?
By our independent recall-safety rating — not an efficacy measure — cardura ranks highest among the products we list for urinary retention. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat urinary retention?
Treatments for urinary retention span FDA drug classes including alpha-adrenergic blocker, cholinesterase inhibitor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.